Vaccine - Publications - Faculty & Research - Harvard Business School

Filter Results: (146)

Filter Results: (146)

Show Results For

← Page 4 of 146 Results →

Sort by

Are you looking for?

→Search All HBS Web

August 2017
Article

Should Governments Invest More in Nudging?

By: Shlomo Benartzi, John Beshears, Katherine L. Milkman, Cass R. Sunstein, Richard H. Thaler, Maya Shankar, Will Tucker-Ray, William J. Congdon and Steven Galing

Governments are increasingly adopting behavioral science techniques for changing individual behavior in pursuit of policy objectives. The types of “nudge” interventions that governments are now adopting alter people’s decisions without coercion or significant changes... View Details

Find at Harvard

05 Oct 2016
Research & Ideas

Why Don't More People Get Flu Shots at Work?

With a yearly price tag of roughly $87 billion in lost productivity and adverse health consequences, the flu is nothing to sneeze at. It’s no surprise that workplace flu vaccination clinics have gained popularity as employers try to keep... View Details

Keywords: by Roberta Holland; Health

January 2025 (Revised March 2025)
Case

Gavi and the 'Next' Pandemic

By: Tarun Khanna and Kerry Herman

In 2025, CEO Dr. Sania Nishtar and her team consider the lessons the Global Alliance for Vaccine and Immunizations (GAVI) learned from the pandemic. GAVI successfully brought COVID-19 vaccines to large swaths of the undeveloped and under-developed world by pooling... View Details

Keywords: Developing Countries and Economies; Health Care and Treatment; Health Pandemics; Crisis Management; Success; Innovation and Invention; Service Delivery; Organizational Change and Adaptation; Strategic Planning; Pharmaceutical Industry; Africa

March 2022 (Revised July 2022)
Case

Nexleaf Analytics: Saving the World Using the Internet of Things

By: Frank Nagle

In 2019, a decade after co-founding Nexleaf Analytics, CEO Nithya Ramanathan faced an important decision that would impact the ability of the small, but growing, not-for-profit organization to thrive for another decade. Their sensor technologies and big data analytics... View Details

Keywords: Corporate Strategy; Collaborative Innovation and Invention; Technological Innovation; Nonprofit Organizations; Competitive Strategy; Patents; Expansion; Information Technology; Health Industry; Information Industry; Medical Devices and Supplies Industry; Technology Industry

Forthcoming
Article

Branch-and-Price for Prescriptive Contagion Analytics

By: Alexandre Jacquillat, Michael Lingzhi Li, Martin Ramé and Kai Wang

Contagion models are ubiquitous in epidemiology, social sciences, engineering, and management. This paper formulates a prescriptive contagion analytics model where a decision maker allocates shared resources across multiple segments of a population, each governed by... View Details

Keywords: COVID-19; Mathematical Methods

Find at Harvard

11 Jun 2020
Working Paper Summaries

Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design

Keywords: by Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver; Health

December 2020 (Revised January 2022)
Supplement

Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)

By: Linda A. Hill and Emily Tedards

In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone three large-scale mergers and acquisitions. As Ku and his new leadership team set out to build a proactive, end-to-end, digital and physical clinical... View Details

Keywords: Digital Technology; Customer-centricity; Innovation; Customer Focus; Talent; Talent Management; Leadership; Innovation and Invention; Transformation; Organizational Culture; Customer Focus and Relationships; Change Management; Talent and Talent Management; Supply Chain; Mission and Purpose

April 18, 2022
Article

Will mRNA Technology Companies Spawn Innovation Ecosystems?

By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern

The mRNA technologies that helped rapidly create effective COVID-19 vaccines could become technology platform businesses, which has tremendous implications for players in the world of drug development. These platforms could attract other companies interested in... View Details

Keywords: Health Care; Digital Health; Technology; Innovation; Health Care and Treatment; Technological Innovation; Digital Transformation; Health Industry; United States

Register to Read

27 Apr 2010
First Look

First Look: April 27

due to economic relations with the EU are a significant component of the perceived network value. Cases & Course MaterialsInternational AIDS Vaccine Initiative Allen Grossman and Catherine RossHarvard Business School Case 310-015... View Details

Keywords: Martha Lagace

November 2022
Case

Goonj: Growing in the Face of a Pandemic

By: V. Kasturi Rangan and Priyank Narayan

Founded by the husband and wife team of Anshu and Meenakshi Gupta in 1999, Goonj had quickly emerged as one of the leading disaster relief and rural development organizations in India. Their main mode of development was through providing a clothing kit to the village... View Details

Keywords: COVID-19 Pandemic; Management; Family Business; Natural Disasters; Social Issues; Entrepreneurship; Operations; Business and Community Relations; Strategy; India

June 2009 (Revised June 2009)
Case

VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture

This case describes the evolution of a liquid petroleum gas (LPG) distributor start-up, incubated by two not-for-profit NGOs to help improve the vaccine cold chain in Northern Mozambique. These NGOs must face the decision whether and how to sell their participation in... View Details

Keywords: Joint Ventures; Supply Chain; Health Care and Treatment; Investment; Non-Governmental Organizations; Energy Sources; Energy Industry; Health Industry; Mozambique

2023
Working Paper

Market Exclusivity and Innovation: Evidence From Antibiotics

By: Edward Kong and Olivia Zhao

The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details

Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States

October 2023 (Revised June 2024)
Case

Catalent: Catalyzing the Next Era of Growth

By: Satish Tadikonda, William Marks and Kevin Emancipator

Catalent's newly appointed CEO, Alessandro Maselli, experienced the highs of the pharmaceutical contract development manufacturing (CDMO) space during COVID-19 while helping Moderna and others bring vaccines to market quickly and safely. After rushing to add capacity... View Details

Keywords: Leadership; Business or Company Management; Organizational Change and Adaptation; Pharmaceutical Industry

Article

What Evolution Can Teach Us About Innovation

By: Noubar Afeyan and Gary P. Pisano

Many people believe that the process for achieving breakthrough innovations is chaotic, random, and unmanageable. But that view is flawed, the authors argue. Breakthroughs can be systematically generated using a process modeled on the principles that drive evolution in... View Details

Keywords: Breakthrough Innovation; Variance Generation; Selection Pressure; Emergent Discovery; Innovation and Invention; Value Creation; Innovation Leadership

Find at Harvard

Register to Read

January 2023
Case

Natura: Weathering the Pandemic at Brazil's Cosmetic Giant

By: Brian Trelstad, Pedro Levindo and Carla Larangeira

Brazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts... View Details

December 2023 (Revised March 2024)
Case

Manufacturing Moderna's Future

By: Satish Tadikonda and William Marks

In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details

Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry

Article

Beyond Good Intentions: Prompting People to Make Plans Improves Follow-through on Important Tasks

By: Todd Rogers, Katherine L Milkman, Leslie K. John and Michael I. Norton

Many intend to stay fit but fail to exercise or eat healthfully; students intend to earn good grades but study too little; citizens intend to vote but fail to turnout. How can policymakers help people follow through on intentions like these? Plan-making, a tool that... View Details

Keywords: Behavior; Success; Planning

Find at Harvard

May 6, 2020
Article

We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic

By: Gary P. Pisano

The ultimate solutions to the COVID-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already... View Details

Keywords: COVID-19; Health Pandemics; Strategy; Leadership

Find at Harvard

March 2022 (Revised March 2024)
Case

Hometown Foods: Changing Price amid Inflation

By: Julian De Freitas, Jeremy Yang and Das Narayandas

During the early part of the 2021 Covid-19 pandemic, Hometown Foods, a large seller of flour-based products, thrived as consumers hoarded baked goods and took up baking to pass the time and find comfort. Then, amid growing shortages in commodities, a vaccine arrived,... View Details

Keywords: COVID-19 Pandemic; Consumer Behavior; Supply Chain; Inflation and Deflation; Spending; Price Bubble; Price; Volatility; Food and Beverage Industry

July 2023
Case

Moderna: Everything, Everywhere, All at Once

By: Satish Tadikonda, Shikhar Ghosh and William Marks

Coming out of the COVID-19 pandemic, Moderna was riding the successes of developing a vaccine in record time and helping stem the tide of the crisis. However, the company had grown at an incredible rate, more than doubled its number of employees, and had to put on hold... View Details

Keywords: Health Pandemics; Selection and Staffing; Growth Management; Management Succession; Retirement; Technological Innovation; Corporate Strategy; Biotechnology Industry

←
4
5
6
7
8
→